Eyman Metanis MPH
Eyman has been involved in building and running many successful international businesses since 2008. Eyman holds a Masters in Public Health Administration and has a vast knowledge of the pharmaceutical industry. Eyman has spent the majority of the last decade growing his companies into successful ventures.
Dr Omar Said PHD
Dr. Omar is the Chief Research Officer and founder of BELEAF PHARMA. Dr. Omar is a pioneer and an expert in the field of Greco-Arab medicine and herbal medicine pharmacology. Dr. Omar has published numerous scientific publications in pharmacology and other fields, and is a recognized expert on the translation of ancient manuscripts. Dr. Omar holds a Doctor of Science degree in Pharmacology.
With over 15 years of sales and management experience, Craig joined the BELEAF PHARMA team in 2018 as the Chief Operating Officer. Involved since the beginning, Craig has played a role in every aspect of building BELEAF PHARMA to where it is today. From overseeing international operations, supply chain management, and product design to licensing, legal, and marketing.
Dr Stephen Fulder
Matej Breznik PHD
Professor Bashar Saed
Dr. Ahmad Yazbak
Professor Iyad Khamaysi
Professor Iyad Khamaysi currently directs the Advanced Endoscopy Unit for the Department of Gastroenterology at the Rambam Health Care Campus. Professor Khamaysi is an industry-leading instructor within the field of Gastroenterology.
Professor Khamaysi is a member of numerous national and international medical societies. He also serves as a scientific consultant for numerous hospitals, medical centers, and medical start-up companies.
Riyad Amin is a professor of biochemistry and has 40 years of experience in clinical biochemistry. He has served as a professor of biochemistry for 22 years, took up the Fulbright Award in 1987, and spent 18 years serving as Chairman of a Biochemistry Department
His research concentrates on natural products and disease management. During his career Riyad participated in three clinical trials in the United States as Sub-Investigator evaluating the safety and efficacy of various drugs for treating: Chronic Obstructive Pulmonary Disorder (COPD), Irritable Bowel Syndrome (IBS) and Hypertension.